$137.91
+0.03
(+0.02%)▲
0.43%
Downside
Day's Volatility :1.35%
Upside
0.93%
38.08%
Downside
52 Weeks Volatility :39.08%
Upside
1.63%
Period | Welltower Inc. | Sector (Real Estate) | S&P500 |
---|---|---|---|
3 Months | 15.66% | 1.7% | 5.9% |
6 Months | 36.72% | 18.0% | 12.5% |
1 Year | 53.88% | 21.4% | 30.9% |
3 Years | 58.39% | -10.3% | 27.0% |
Market Capitalization | 85.9B |
Book Value | $49.05 |
Dividend Share | 2.56 |
Dividend Yield | 1.95% |
Earnings Per Share (EPS) | 1.57 |
PE Ratio | 87.82 |
PEG Ratio | 2.33 |
Wall Street Target Price | 136.368 |
Profit Margin | 12.12% |
Operating Margin TTM | 17.37% |
Return On Assets TTM | 1.85% |
Return On Equity TTM | 3.42% |
Revenue TTM | 7.6B |
Revenue Per Share TTM | 12.94 |
Quarterly Revenue Growth YOY | 28.799999999999997% |
Gross Profit TTM | 2.3B |
EBITDA | 2.9B |
Diluted Eps TTM | 1.57 |
Quarterly Earnings Growth YOY | 2.0 |
EPS Estimate Current Year | 1.46 |
EPS Estimate Next Year | 1.91 |
EPS Estimate Current Quarter | 0.38 |
EPS Estimate Next Quarter | 0.4 |
What analysts predicted
Downside of 1.12%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 4.7B | ↑ 8.89% |
Net Income | 805.0M | ↑ 53.98% |
Net Profit Margin | 17.12% | ↑ 5.01% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 5.1B | ↑ 8.95% |
Net Income | 539.9M | ↓ 32.92% |
Net Profit Margin | 10.54% | ↓ 6.58% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 4.6B | ↓ 10.06% |
Net Income | -41.5M | ↓ 107.69% |
Net Profit Margin | -0.9% | ↓ 11.44% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 4.7B | ↑ 2.96% |
Net Income | 162.0M | ↓ 490.26% |
Net Profit Margin | 3.42% | ↑ 4.32% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 5.9B | ↑ 23.59% |
Net Income | 141.2M | ↓ 12.85% |
Net Profit Margin | 2.41% | ↓ 1.01% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 6.6B | ↑ 13.16% |
Net Income | 340.1M | ↑ 140.84% |
Net Profit Margin | 5.13% | ↑ 2.72% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↑ 6.71% |
Net Income | 103.0M | ↑ 194.75% |
Net Profit Margin | 6.19% | ↑ 3.95% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↓ 0.21% |
Net Income | 127.5M | ↑ 23.71% |
Net Profit Margin | 7.67% | ↑ 1.48% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↑ 5.22% |
Net Income | 83.9M | ↓ 34.17% |
Net Profit Margin | 4.8% | ↓ 2.87% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.9B | ↑ 6.29% |
Net Income | 127.1M | ↑ 51.52% |
Net Profit Margin | 6.84% | ↑ 2.04% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.8B | ↓ 1.88% |
Net Income | 254.7M | ↑ 100.33% |
Net Profit Margin | 13.97% | ↑ 7.13% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 2.0B | ↑ 10.27% |
Net Income | 449.8M | ↑ 76.61% |
Net Profit Margin | 22.37% | ↑ 8.4% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 30.3B | ↑ 8.58% |
Total Liabilities | 14.3B | ↑ 13.35% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 33.4B | ↑ 10.01% |
Total Liabilities | 16.4B | ↑ 14.42% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 32.5B | ↓ 2.69% |
Total Liabilities | 15.3B | ↓ 6.95% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 34.9B | ↑ 7.47% |
Total Liabilities | 15.9B | ↑ 4.29% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 37.9B | ↑ 8.54% |
Total Liabilities | 16.5B | ↑ 3.69% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 44.0B | ↑ 16.15% |
Total Liabilities | 17.6B | ↑ 6.92% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 40.1B | ↑ 4.08% |
Total Liabilities | 17.9B | ↑ 5.76% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 41.7B | ↑ 3.97% |
Total Liabilities | 17.8B | ↓ 0.2% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 44.0B | ↑ 5.66% |
Total Liabilities | 17.6B | ↓ 1.1% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 44.6B | ↑ 1.23% |
Total Liabilities | 16.0B | ↓ 9.27% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 45.5B | ↑ 2.2% |
Total Liabilities | 15.8B | ↓ 1.0% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 49.0B | ↑ 7.51% |
Total Liabilities | 17.9B | ↑ 12.9% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.6B | ↑ 10.44% |
Investing Cash Flow | -2.4B | ↓ 1643.83% |
Financing Cash Flow | 818.4M | ↓ 142.77% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.5B | ↓ 3.03% |
Investing Cash Flow | -2.0B | ↓ 14.15% |
Financing Cash Flow | 577.2M | ↓ 29.48% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.4B | ↓ 11.15% |
Investing Cash Flow | 2.3B | ↓ 214.6% |
Financing Cash Flow | -2.1B | ↓ 460.54% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.3B | ↓ 6.55% |
Investing Cash Flow | -4.5B | ↓ 292.35% |
Financing Cash Flow | 1.6B | ↓ 175.34% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.3B | ↑ 4.19% |
Investing Cash Flow | -3.7B | ↓ 17.99% |
Financing Cash Flow | 2.8B | ↑ 76.14% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 416.2M | ↑ 10.69% |
Investing Cash Flow | -393.4M | ↓ 57.83% |
Financing Cash Flow | 1.6B | ↑ 246.85% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 439.1M | ↑ 5.48% |
Investing Cash Flow | -1.2B | ↑ 214.54% |
Financing Cash Flow | 1.2B | ↓ 25.92% |
Sell
Neutral
Buy
Welltower Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Welltower Inc. | 4.45% | 36.72% | 53.88% | 58.39% | 65.78% |
Healthpeak Properties, Inc. | -6.0% | 13.19% | 92.35% | 17.31% | 17.44% |
Ventas, Inc. | -3.65% | 33.79% | 40.88% | 23.81% | 10.25% |
Omega Healthcare Investors Inc. | -3.86% | 27.45% | 25.23% | 37.46% | -3.67% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Welltower Inc. | 87.82 | 87.82 | 2.33 | 1.46 | 0.03 | 0.02 | 0.02 | 49.05 |
Healthpeak Properties, Inc. | 44.31 | 44.31 | 4.08 | 0.15 | 0.04 | 0.02 | 0.06 | 12.24 |
Ventas, Inc. | 2223.5 | NA | 2.28 | 0.0 | -0.01 | 0.02 | 0.03 | 23.28 |
Omega Healthcare Investors Inc. | 29.51 | 29.51 | 1.13 | 1.51 | 0.09 | 0.04 | 0.07 | 15.69 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Welltower Inc. | Buy | $85.9B | 65.78% | 87.82 | 12.12% |
Healthpeak Properties, Inc. | Buy | $15.2B | 17.44% | 44.31 | 12.11% |
Ventas, Inc. | Buy | $27.0B | 10.25% | 2223.5 | -1.39% |
Omega Healthcare Investors Inc. | Hold | $11.1B | -3.67% | 29.51 | 34.41% |
Insights on Welltower Inc.
Revenue is up for the last 2 quarters, 1.82B → 2.01B (in $), with an average increase of 9.3% per quarter
Netprofit is up for the last 4 quarters, 83.91M → 449.84M (in $), with an average increase of 42.5% per quarter
In the last 1 year, Healthpeak Properties, Inc. has given 92.3% return, outperforming this stock by 38.4%
Vanguard Group Inc
BlackRock Inc
Cohen & Steers Inc
Capital Research & Mgmt Co - Division 3
State Street Corp
NORGES BANK
In the quarter ending March,2024. Welltower Inc. has declared dividend of $0.61
Read Morehealth care reit, inc. is now welltower™ welltower™ is a recognized leader in providing consistent, low-cost capital to fund health care infrastructure and real estate. our business structure as a publically traded reit (nyse:hcn) provides us with opportunities to fund innovative solutions designed to keep patients out of higher cost, higher acuity settings while delivering better treatment at lower cost. global demographic and social trends, notably the aging of the population, require vast investments and infrastructure development. the devastating impact of dementia on people and their families demands new solutions. together with our operating partners, we’re creating environments that help our partners meet the challenges of this complicated and rapidly changing market. welltower™ partners with some of the most innovative health systems and seniors housing operators to grow their platforms and support the evolution of health care. together with our partners, we seek to drive
Organization | Welltower Inc. |
Employees | 533 |
CEO | Mr. Shankh S. Mitra |
Industry | Finance |
Eastman Chemical Co.
$137.91
+0.02%
Jack Henry & Associates Inc.
$137.91
+0.02%
Bunge Limited
$137.91
+0.02%
Apache Corp.
$137.91
+0.02%
Edwards Lifesciences Corp.
$137.91
+0.02%
Cognizant Technology Solutions Corp.
$137.91
+0.02%
At&t, Inc.
$137.91
+0.02%
Small Cap Etf Vanguard
$137.91
+0.02%
Constellation Brands Inc.
$137.91
+0.02%